Current status of superoxide dismutase 2 on oral disease progression by supervision of ROS.
- 2024-06
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 175
- Dian Ding
- Na Li
- Yihong Ge
- Hongle Wu
- Jinzhao Yu
- Wei Qiu
- Fuchun Fang
- PubMed: 38688168
- DOI: 10.1016/j.biopha.2024.116605
Study Design
- Type
- Review
The recent Global Burden of Disease results have demonstrated that oral diseases are some of the most significant public health challenges facing the world. Owing to its specific localization advantage, superoxide dismutase 2 (SOD2 or MnSOD) has the ability to process the reactive oxygen species (ROS) produced by mitochondrial respiration before anything else, thereby impacting the occurrence and development of diseases. In this review, we summarize the processes of common oral diseases in which SOD2 is involved. SOD2 is upregulated in periodontitis to protect the tissue from the distant damage caused by excessive ROS and further reduce inflammatory progression. SOD2 also participates in the specific pathogenesis of oral cancers and dental diseases. The clinical application prospects of SOD2 in oral diseases will be discussed further, referencing the differences and relationship between oral diseases and other clinical systemic diseases.